The Five-Item Modified Frailty Index (mFI-5) Predicts Adverse Short-term Outcomes in Patients Undergoing Mastectomy: A Propensity Score-Matched Analysis of 252,054 Cases.

IF 2.9 3区 医学 Q2 ONCOLOGY
Felix J Klimitz, Fortunay Diatta, Joshua Freeman, Thomas Schaschinger, Stav Brown, Samuel Knoedler, Gabriel Hundeshagen, Martin Kauke-Navarro, Bohdan Pomahac, Adriana C Panayi
{"title":"The Five-Item Modified Frailty Index (mFI-5) Predicts Adverse Short-term Outcomes in Patients Undergoing Mastectomy: A Propensity Score-Matched Analysis of 252,054 Cases.","authors":"Felix J Klimitz, Fortunay Diatta, Joshua Freeman, Thomas Schaschinger, Stav Brown, Samuel Knoedler, Gabriel Hundeshagen, Martin Kauke-Navarro, Bohdan Pomahac, Adriana C Panayi","doi":"10.1016/j.clbc.2025.03.015","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Frailty has emerged as a critical predictor of postoperative outcomes, particularly in older surgical patients. However, its role in mastectomy patients remains underexplored. This study evaluates the utility of the 5-item Modified Frailty Index (mFI-5) in predicting 30-day postoperative complications in mastectomy patients, aiming to improve risk stratification and inform clinical decision-making.</p><p><strong>Methods: </strong>A retrospective analysis using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was conducted from 2008 to 2022. Patients were categorized into high-risk (mFI-5 ≥ 2) and low-risk (mFI-5 < 2) groups. Propensity score matching (PSM) was applied to create balanced cohorts and multivariate logistic regression was used to evaluate associations between frailty and postoperative outcomes.</p><p><strong>Results: </strong>Of the 252,054 adult female patients who underwent mastectomy, 1.2 % were identified as high-risk frail. High-risk patients were older (70 ± 9.9 vs. 60 ± 14 years, P < .001) and had a higher BMI (35 ± 9.1 vs. 29 ± 7.1 kg/m², P < .001) compared to low-risk patients. After PSM, high-risk patients had significantly higher odds of any complication (OR: 2.05, 95 % CI: 1.70-2.47, P < .001), surgical complications (OR: 1.70, 95 % CI: 1.38-2.10, P < .001), and medical complications (OR: 3.81, 95 % CI: 2.64-5.50, P < .001). Key complications included infections, bleeding requiring transfusion, and unplanned readmissions.</p><p><strong>Conclusion: </strong>The mFI-5 effectively identifies mastectomy patients at higher risk of postoperative complications, including medical complications and unplanned reoperation or readmission, underscoring its value in preoperative risk stratification. Incorporating frailty assessments into clinical practice could enhance surgical decision-making, optimize resource allocation, and improve patient outcomes.</p>","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clbc.2025.03.015","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Frailty has emerged as a critical predictor of postoperative outcomes, particularly in older surgical patients. However, its role in mastectomy patients remains underexplored. This study evaluates the utility of the 5-item Modified Frailty Index (mFI-5) in predicting 30-day postoperative complications in mastectomy patients, aiming to improve risk stratification and inform clinical decision-making.

Methods: A retrospective analysis using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was conducted from 2008 to 2022. Patients were categorized into high-risk (mFI-5 ≥ 2) and low-risk (mFI-5 < 2) groups. Propensity score matching (PSM) was applied to create balanced cohorts and multivariate logistic regression was used to evaluate associations between frailty and postoperative outcomes.

Results: Of the 252,054 adult female patients who underwent mastectomy, 1.2 % were identified as high-risk frail. High-risk patients were older (70 ± 9.9 vs. 60 ± 14 years, P < .001) and had a higher BMI (35 ± 9.1 vs. 29 ± 7.1 kg/m², P < .001) compared to low-risk patients. After PSM, high-risk patients had significantly higher odds of any complication (OR: 2.05, 95 % CI: 1.70-2.47, P < .001), surgical complications (OR: 1.70, 95 % CI: 1.38-2.10, P < .001), and medical complications (OR: 3.81, 95 % CI: 2.64-5.50, P < .001). Key complications included infections, bleeding requiring transfusion, and unplanned readmissions.

Conclusion: The mFI-5 effectively identifies mastectomy patients at higher risk of postoperative complications, including medical complications and unplanned reoperation or readmission, underscoring its value in preoperative risk stratification. Incorporating frailty assessments into clinical practice could enhance surgical decision-making, optimize resource allocation, and improve patient outcomes.

五项修正虚弱指数(mFI-5)预测乳房切除术患者的短期不良预后:252,054例倾向评分匹配分析。
背景:虚弱已成为术后预后的关键预测因素,特别是在老年手术患者中。然而,其在乳房切除术患者中的作用仍未得到充分探讨。本研究评估5项修正虚弱指数(mFI-5)在预测乳房切除术患者术后30天并发症中的效用,旨在改善风险分层,为临床决策提供信息。方法:对2008年至2022年美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库进行回顾性分析。将患者分为高危组(mFI-5≥2)和低危组(mFI-5 < 2)。倾向评分匹配(PSM)用于创建平衡队列,多变量逻辑回归用于评估虚弱和术后结果之间的关联。结果:在接受乳房切除术的252,054名成年女性患者中,1.2%被确定为高危体弱。与低危患者相比,高危患者年龄较大(70±9.9比60±14岁,P < .001), BMI较高(35±9.1比29±7.1 kg/m²,P < .001)。PSM后,高危患者出现任何并发症(OR: 2.05, 95% CI: 1.70 ~ 2.47, P < 0.001)、手术并发症(OR: 1.70, 95% CI: 1.38 ~ 2.10, P < 0.001)和内科并发症(OR: 3.81, 95% CI: 2.64 ~ 5.50, P < 0.001)的几率均显著增高。主要并发症包括感染、需要输血的出血和意外再入院。结论:mFI-5可有效识别乳房切除术患者术后并发症风险较高的患者,包括内科并发症和计划外再手术或再入院,突出了其术前风险分层的价值。将衰弱评估纳入临床实践可以加强手术决策,优化资源分配,改善患者预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical breast cancer
Clinical breast cancer 医学-肿瘤学
CiteScore
5.40
自引率
3.20%
发文量
174
审稿时长
48 days
期刊介绍: Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信